Qureator proudly announces the promotion of Dr. Tsung-li Liu to Chief Technology Officer (CTO). Over the past three years, Dr. Liu has been a driving force behind Qureator’s technological innovation, helping to advance the company’s mission to revolutionize drug discovery through AI-powered human disease models. His leadership has been pivotal in developing next-generation platforms that bridge human biology and computational intelligence. As CTO, Dr. Liu will continue to steer Qureator’s technology strategy, accelerating breakthroughs that enable faster, more predictive, and more human-relevant therapeutic development. We are excited to move into this next phase of growth under his visionary leadership.